These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 29328352)
1. New Drugs & Indications for 2017: The Year in Review. J Psychosoc Nurs Ment Health Serv; 2018 Jan; 56(1):19. PubMed ID: 29328352 [No Abstract] [Full Text] [Related]
2. Narcotic pain relievers: are you using them correctly? Johns Hopkins Med Lett Health After 50; 2012 Nov; 24(10):1-2. PubMed ID: 23362527 [No Abstract] [Full Text] [Related]
3. FDA chief defends Zohydro approval as US states rebel. McCarthy M BMJ; 2014 Apr; 348():g2939. PubMed ID: 24764572 [No Abstract] [Full Text] [Related]
4. US bill would force FDA to withdraw approval of new pain drug Zohydro. McCarthy M BMJ; 2014 Mar; 348():g2195. PubMed ID: 24637611 [No Abstract] [Full Text] [Related]
5. The US Military Considers Whether Controversial Opioid Is Fit for Battlefield Duty. Voelker R JAMA; 2019 Jun; 321(24):2389-2391. PubMed ID: 31166592 [No Abstract] [Full Text] [Related]
6. Both Urgency and Balance Needed in Addressing Opioid Epidemic: A Report From the National Academies of Sciences, Engineering, and Medicine. Bonnie RJ; Kesselheim AS; Clark DJ JAMA; 2017 Aug; 318(5):423-424. PubMed ID: 28715551 [No Abstract] [Full Text] [Related]
7. Esketamine for Treatment-Resistant Depression - First FDA-Approved Antidepressant in a New Class. Kim J; Farchione T; Potter A; Chen Q; Temple R N Engl J Med; 2019 Jul; 381(1):1-4. PubMed ID: 31116916 [No Abstract] [Full Text] [Related]
8. New drug to restore bowel function approved under new FDA rules. Lavine G Am J Health Syst Pharm; 2008 Jul; 65(13):1204. PubMed ID: 18574004 [No Abstract] [Full Text] [Related]
9. Patients see proposed FDA opioid rules as painfully restrictive. Brower V Nat Med; 2009 Aug; 15(8):827. PubMed ID: 19661971 [No Abstract] [Full Text] [Related]
10. FDA Approval of Extended-Release Oxycodone for Children With Severe Pain. Yang YT; Chen B; Bennett CL Pediatrics; 2016 May; 137(5):. PubMed ID: 27244829 [No Abstract] [Full Text] [Related]
11. FDA-Approved Drugs to Treat Major Depressive Disorder (MDD). J Psychosoc Nurs Ment Health Serv; 2024 Jul; 62(7):5-6. PubMed ID: 38976854 [No Abstract] [Full Text] [Related]
12. Evening the score on sex drugs: feminist movement or marketing masquerade? Moynihan R BMJ; 2014 Oct; 349():g6246. PubMed ID: 25354348 [No Abstract] [Full Text] [Related]
13. Extended-release hydrocodone (Zohydro) for pain. Med Lett Drugs Ther; 2014 Jun; 56(1444):45-6. PubMed ID: 24933087 [No Abstract] [Full Text] [Related]
14. FDA approves oxycodone and acetaminophen extended-release tablets. J Pain Palliat Care Pharmacother; 2014 Jun; 28(2):188-9. PubMed ID: 25011144 [No Abstract] [Full Text] [Related]
15. Close vote by FDA advisers favors propoxyphene withdrawal. Traynor K Am J Health Syst Pharm; 2009 Mar; 66(6):518-20. PubMed ID: 19265176 [No Abstract] [Full Text] [Related]
16. Gender in the pharmacy: does it matter? Kaiser J Science; 2005 Jun; 308(5728):1572. PubMed ID: 15947169 [No Abstract] [Full Text] [Related]
17. OxyContin, the media, and law enforcement. Baumrucker SJ Am J Hosp Palliat Care; 2001; 18(3):154-6. PubMed ID: 11406885 [No Abstract] [Full Text] [Related]
18. Thinking outside the (black) box: antidepressants, suicidality, and research synthesis. Greenhouse JB; Kelleher KJ Pediatrics; 2005 Jul; 116(1):231-3. PubMed ID: 15995059 [No Abstract] [Full Text] [Related]
19. Tramadol extended-release tablets in moderate to moderately severe chronic pain in adults: profile report. Hair PI; Curran MP; Keam SJ CNS Drugs; 2007; 21(3):259-63. PubMed ID: 17338595 [No Abstract] [Full Text] [Related]
20. Vortioxetine (Brintellix®) and levomilnacipran (Fetzima®): the two newest additions to the antidepressant formulary. Roman MW; Wilkinson SM Issues Ment Health Nurs; 2014 Dec; 35(12):972-4. PubMed ID: 25426751 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]